It has been hypothesized that the best candidate for anti-TNF therapy is a young, non-smoking patient with short CD duration, colonic disease location, non-stricturing CD behavior, having high CRP concentration and who had not been previously treated surgically4, 16, 17, 18. This evidence concerns the gene TNF and colonic disorder.